"Die Fachklinik Hornheide ist ein interdisziplinäres und überregionales Zentrum für die Behandlung von Tumoren der Haut, des Kopf-Hals-Bereichs sowie chirurgischer Rekonstruktion."

During the past decade, Fachklinik Hornheide; Dermatologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fachklinik Hornheide; Dermatologie" are "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Basal Cell Carcinoma" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "Fachklinik Hornheide; Dermatologie" in a lesser frequency.

Most popular intervention types in "Fachklinik Hornheide; Dermatologie" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Cobimetinib" (2 trials), "Atezolizumab Placebo" (1 trials), "Pembrolizumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fachklinik Hornheide; Dermatologie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Fachklinik Hornheide; Dermatologie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Fachklinik Hornheide; Dermatologie, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fachklinik Hornheide; Dermatologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".